<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-08T20:23:18+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>独家专访复宏汉霖CEO张文杰：复宏汉霖进入发展第二阶段，要实现生物类似药和创新药双领导地位</title>
    <updated>2020-12-08T20:09:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/91guZL-GiHUE7zFCwpwIKQ</id>
    <link href="https://mp.weixin.qq.com/s/91guZL-GiHUE7zFCwpwIKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他说：一般一年两次集采！500个品种动态调整，量大、竞争激烈优先纳入？</title>
    <updated>2020-12-08T20:09:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/9AkvXPoAE6oJCAdiD3y7_Q</id>
    <link href="https://mp.weixin.qq.com/s/9AkvXPoAE6oJCAdiD3y7_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！恒瑞医药卡瑞利珠单抗+苹果酸法米替尼联合疗法被纳入拟突破性治疗品种公示</title>
    <updated>2020-12-08T20:09:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/o9EAbcKqdKVwEOfSr93cyg</id>
    <link href="https://mp.weixin.qq.com/s/o9EAbcKqdKVwEOfSr93cyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【投资人观点】京东健康首日市值超阿里健康，怎么看医药电商估值的高与低？</title>
    <updated>2020-12-08T20:09:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/feF_tI41Ilj9zs724e6vew</id>
    <link href="https://mp.weixin.qq.com/s/feF_tI41Ilj9zs724e6vew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>30年医药产业资本浮沉，沃森生物有点“嫩”！</title>
    <updated>2020-12-07T21:20:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/z5GRaIwkLCzDQ_UDvRTzmA</id>
    <link href="https://mp.weixin.qq.com/s/z5GRaIwkLCzDQ_UDvRTzmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>被高瓴称为“新冠疫苗黑马”，年产量可达10亿剂，获超20亿元国际资助，这家创新药企凭什么？</title>
    <updated>2020-12-07T21:20:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/GW43Qfz9ChBIhmfNnKsLFg</id>
    <link href="https://mp.weixin.qq.com/s/GW43Qfz9ChBIhmfNnKsLFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Ⅱ期临床成功率被提升2倍！辉瑞如何做到的？</title>
    <updated>2020-12-07T21:20:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/Pr1ddCAdgjJTH09PXqBtxA</id>
    <link href="https://mp.weixin.qq.com/s/Pr1ddCAdgjJTH09PXqBtxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞员工评价孙飘扬：他真的是喜欢研发！</title>
    <updated>2020-12-06T18:34:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/-eNf6L-57mzQUUILWAEDdA</id>
    <link href="https://mp.weixin.qq.com/s/-eNf6L-57mzQUUILWAEDdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不选择license in，看璎黎药业的从0到1之路</title>
    <updated>2020-12-06T18:34:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/Fq44bY_k3C2rRpEM5fXHxQ</id>
    <link href="https://mp.weixin.qq.com/s/Fq44bY_k3C2rRpEM5fXHxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一笔刷历史新高的license out背后，biotech如何跑步进入2.0</title>
    <updated>2020-12-05T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/S22hgitS2j7flKBH3fnBPg</id>
    <link href="https://mp.weixin.qq.com/s/S22hgitS2j7flKBH3fnBPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>老药新用，滚动开发！解密亚虹研发策略，为什么他能做成？</title>
    <updated>2020-12-05T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/snrEaEfMSXexlFpzGNe5qQ</id>
    <link href="https://mp.weixin.qq.com/s/snrEaEfMSXexlFpzGNe5qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>研发费用平均增长45% ，A+H疫苗第一股康希诺的创新逻辑</title>
    <updated>2020-12-05T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/sbovFQGkXG31lQE2f2gglQ</id>
    <link href="https://mp.weixin.qq.com/s/sbovFQGkXG31lQE2f2gglQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国医药产业社会责任公益线上展——一群人的力量和坚持可以改变历史</title>
    <updated>2020-12-05T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/kY7j2FHTcpiCYF-aeC70YA</id>
    <link href="https://mp.weixin.qq.com/s/kY7j2FHTcpiCYF-aeC70YA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4000家药企仅10%有药物警戒团队！GVP出台影响所有MAH！</title>
    <updated>2020-12-04T21:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/OZ8BfKsqTpWEq9_ul7xI6g</id>
    <link href="https://mp.weixin.qq.com/s/OZ8BfKsqTpWEq9_ul7xI6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛、再鼎、天演一众Biotech狂揽人才！CRO公司：不要再从我们这挖人了？</title>
    <updated>2020-12-04T21:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/8FXq-umPgrtcD6NiILZFQQ</id>
    <link href="https://mp.weixin.qq.com/s/8FXq-umPgrtcD6NiILZFQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>甘肃215个药品撤废后的思考？是什么原因？会成为常态吗？解在哪儿？</title>
    <updated>2020-12-04T21:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/yvep6U4mn8J8jcCV3eDDIA</id>
    <link href="https://mp.weixin.qq.com/s/yvep6U4mn8J8jcCV3eDDIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中药市值一哥深耕化药！集采重压下，中药企业如何突围？</title>
    <updated>2020-12-03T22:14:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/-n5yiPBTVnsVSKFeSU3boA</id>
    <link href="https://mp.weixin.qq.com/s/-n5yiPBTVnsVSKFeSU3boA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！丁香医生数据研究院发布《OTC 感冒药市场研究》报告</title>
    <updated>2020-12-03T22:14:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/Wmo_SVPqxIu_AH0q45_JOw</id>
    <link href="https://mp.weixin.qq.com/s/Wmo_SVPqxIu_AH0q45_JOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞、万春、传奇等10新药获突破性治疗认证！审批快车道能否助力中国创新走向全球！</title>
    <updated>2020-12-03T22:14:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/DxA6QrXgCsrpRlcdPGMD5w</id>
    <link href="https://mp.weixin.qq.com/s/DxA6QrXgCsrpRlcdPGMD5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国医药创新真的进入全球第二梯队了吗？之后的路该怎么走？科学监管体系该如何建？</title>
    <updated>2020-12-02T23:28:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/Qm9y2uovqUBTVb3OdJ6klw</id>
    <link href="https://mp.weixin.qq.com/s/Qm9y2uovqUBTVb3OdJ6klw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>